|
TVIS44037544
|
Human T-lymphotropic Virus |
- |
- |
- |
- |
hg38 |
chr1 |
163323033 |
163323033 |
q23.3 |
NUF2 |
Tumor |
Asymptomatic carrier |
High throughput sequenicng |
35654946 |
2022 |
Curated |
|
TVIS44037545
|
Human T-lymphotropic Virus |
- |
- |
- |
- |
hg38 |
chr1 |
163323015 |
163323015 |
q23.3 |
NUF2 |
Tumor |
Asymptomatic carrier |
High throughput sequenicng |
35654946 |
2022 |
Curated |
|
TVIS44037546
|
Human T-lymphotropic Virus |
- |
- |
- |
- |
hg38 |
chr1 |
163323007 |
163323007 |
q23.3 |
NUF2 |
Tumor |
Asymptomatic carrier |
High throughput sequenicng |
35654946 |
2022 |
Curated |
|
TVIS44037547
|
Human T-lymphotropic Virus |
- |
- |
- |
- |
hg38 |
chr1 |
162717144 |
162717144 |
q23.3 |
DDR2 |
Tumor |
Asymptomatic carrier |
High throughput sequenicng |
35654946 |
2022 |
Curated |
|
TVIS44037548
|
Human T-lymphotropic Virus |
- |
- |
- |
- |
hg38 |
chr1 |
162717138 |
162717138 |
q23.3 |
DDR2 |
Tumor |
Asymptomatic carrier |
High throughput sequenicng |
35654946 |
2022 |
Curated |
|
TVIS44037549
|
Human T-lymphotropic Virus |
- |
- |
- |
- |
hg38 |
chr1 |
162650359 |
162650359 |
q23.3 |
DDR2 |
Tumor |
Asymptomatic carrier |
High throughput sequenicng |
35654946 |
2022 |
Curated |
|
TVIS44037550
|
Human T-lymphotropic Virus |
- |
- |
- |
- |
hg38 |
chr1 |
162486854 |
162486854 |
q23.3 |
ENSG00000308263 |
Tumor |
Asymptomatic carrier |
High throughput sequenicng |
35654946 |
2022 |
Curated |
|
TVIS44037551
|
Human T-lymphotropic Virus |
- |
- |
- |
- |
hg38 |
chr1 |
161745885 |
161745885 |
q23.3 |
- |
Tumor |
Asymptomatic carrier |
High throughput sequenicng |
35654946 |
2022 |
Curated |
|
TVIS44037552
|
Human T-lymphotropic Virus |
- |
- |
- |
- |
hg38 |
chr1 |
160980465 |
160980465 |
q23.3 |
- |
Tumor |
Asymptomatic carrier |
High throughput sequenicng |
35654946 |
2022 |
Curated |
|
TVIS44037553
|
Human T-lymphotropic Virus |
- |
- |
- |
- |
hg38 |
chr1 |
160480973 |
160480973 |
q23.2 |
- |
Tumor |
Asymptomatic carrier |
High throughput sequenicng |
35654946 |
2022 |
Curated |